Study Title

perspectivetherapeutics

A Phase I/IIa First-in-Human Study of [212Pb]VMT-α-NET Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors

Study Details

Description:

This study is Phase I/IIa First-in-Human Study of [212Pb]VMT-α-NET Targeted Alpha-Particle Therapy for Advanced SSTR2 Positive Neuroendocrine Tumors

Sponsor:

Perspective Therapeutics

Contacts:

Markus Puhlmann, MD, MBA

mpuhlmann@perspectivetherapeutics.com

(319) 665-2150

Government Study Link:

NCT05636618 - Click here to see study on

ClinicalTrials.gov

Patient Education

Patient Education Not Yet Provided

Publications

Publications Not Yet Provided

Locations

United States

Mayo Clinic - Rochester

Rochester, Minnesota, United States

This badge indicates the Principal Investigator has a proven record of excellence in the advancement of Theranostics.


University of Kentucky

Lexington, Kentucky 40536, United States

This badge indicates the Principal Investigator has a proven record of excellence in the advancement of Theranostics.


University of Iowa Medical Center

Iowa City, Iowa, United States

This badge indicates the Principal Investigator has a proven record of excellence in the advancement of Theranostics.


Mayo Clinic - Jacksonville

Jacksonville, Florida, United States

This badge indicates the Principal Investigator has a proven record of excellence in the advancement of Theranostics.
Johns Hopkins University

Baltimore, Maryland 21287, United States

This badge indicates the Principal Investigator has a proven record of excellence in the advancement of Theranostics.
Washington University School of Medicine

St. Louis, Missouri, United States

This badge indicates the Principal Investigator has a proven record of excellence in the advancement of Theranostics.
University of Chicago

Chicago, Illinois 60637, United States

This badge indicates the Principal Investigator has a proven record of excellence in the advancement of Theranostics.
Nebraska Cancer Specialists

Omaha, Nebraska, United States

This badge indicates the Principal Investigator has a proven record of excellence in the advancement of Theranostics.

© 2021 XCancer Software LLC

Contact XCancer: 402-991-8468